PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RMD vs. DXCM
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


RMDDXCM
YTD Return27.08%0.20%
1Y Return-2.22%0.61%
3Y Return (Ann)2.01%5.66%
5Y Return (Ann)17.02%32.02%
10Y Return (Ann)17.50%31.45%
Sharpe Ratio-0.04-0.01
Daily Std Dev39.96%40.16%
Max Drawdown-61.60%-94.61%
Current Drawdown-25.06%-23.63%

Fundamentals


RMDDXCM
Market Cap$26.31B$50.39B
EPS$6.05$1.29
PE Ratio29.56101.33
PEG Ratio1.752.53
Revenue (TTM)$4.50B$3.62B
Gross Profit (TTM)$2.39B$1.88B
EBITDA (TTM)$1.37B$783.70M

Correlation

-0.50.00.51.00.3

The correlation between RMD and DXCM is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

RMD vs. DXCM - Performance Comparison

In the year-to-date period, RMD achieves a 27.08% return, which is significantly higher than DXCM's 0.20% return. Over the past 10 years, RMD has underperformed DXCM with an annualized return of 17.50%, while DXCM has yielded a comparatively higher 31.45% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%NovemberDecember2024FebruaryMarchApril
62.87%
39.25%
RMD
DXCM

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


ResMed Inc.

DexCom, Inc.

Risk-Adjusted Performance

RMD vs. DXCM - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


RMD
Sharpe ratio
The chart of Sharpe ratio for RMD, currently valued at -0.04, compared to the broader market-2.00-1.000.001.002.003.004.00-0.04
Sortino ratio
The chart of Sortino ratio for RMD, currently valued at 0.23, compared to the broader market-4.00-2.000.002.004.006.000.23
Omega ratio
The chart of Omega ratio for RMD, currently valued at 1.03, compared to the broader market0.501.001.501.03
Calmar ratio
The chart of Calmar ratio for RMD, currently valued at -0.03, compared to the broader market0.002.004.006.00-0.03
Martin ratio
The chart of Martin ratio for RMD, currently valued at -0.06, compared to the broader market0.0010.0020.0030.00-0.06
DXCM
Sharpe ratio
The chart of Sharpe ratio for DXCM, currently valued at -0.01, compared to the broader market-2.00-1.000.001.002.003.004.00-0.01
Sortino ratio
The chart of Sortino ratio for DXCM, currently valued at 0.27, compared to the broader market-4.00-2.000.002.004.006.000.27
Omega ratio
The chart of Omega ratio for DXCM, currently valued at 1.03, compared to the broader market0.501.001.501.03
Calmar ratio
The chart of Calmar ratio for DXCM, currently valued at -0.01, compared to the broader market0.002.004.006.00-0.01
Martin ratio
The chart of Martin ratio for DXCM, currently valued at -0.03, compared to the broader market0.0010.0020.0030.00-0.03

RMD vs. DXCM - Sharpe Ratio Comparison

The current RMD Sharpe Ratio is -0.04, which is lower than the DXCM Sharpe Ratio of -0.01. The chart below compares the 12-month rolling Sharpe Ratio of RMD and DXCM.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.50NovemberDecember2024FebruaryMarchApril
-0.04
-0.01
RMD
DXCM

Dividends

RMD vs. DXCM - Dividend Comparison

RMD's dividend yield for the trailing twelve months is around 0.86%, while DXCM has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
RMD
ResMed Inc.
0.86%1.07%0.83%0.62%0.73%0.98%1.26%1.61%2.03%2.16%1.89%1.78%
DXCM
DexCom, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

RMD vs. DXCM - Drawdown Comparison

The maximum RMD drawdown since its inception was -61.60%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for RMD and DXCM. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2024FebruaryMarchApril
-25.06%
-23.63%
RMD
DXCM

Volatility

RMD vs. DXCM - Volatility Comparison

ResMed Inc. (RMD) has a higher volatility of 20.40% compared to DexCom, Inc. (DXCM) at 13.41%. This indicates that RMD's price experiences larger fluctuations and is considered to be riskier than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%NovemberDecember2024FebruaryMarchApril
20.40%
13.41%
RMD
DXCM

Financials

RMD vs. DXCM - Financials Comparison

This section allows you to compare key financial metrics between ResMed Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items